The 5-Minute Ticker – One stock, two friends, five minutes

Scholar Rock Holding Corporation ($SRRK) is a Cambridge-founded, clinical-stage biopharma built by top academic scientists around a platform that targets protein growth factors. In this episode we track their long, painstaking journey to the brink of commercialization: a pivotal Phase 3 win for their lead drug apitegromab in spinal muscular atrophy (an add-on designed to boost muscle function) tha...

Cidara Therapeutics ($CDTX) pulled off a dramatic strategic pivot that just paid off. After selling the rights to its only approved antifungal to double down on a proprietary drug platform called Cloudbreak, the company developed Drug-Fc Conjugates (DFCs) and advanced a lead candidate, CD388 — a potential single-dose, season-long preventative for influenza A and B. Strong mid-stage data attracted...

MicroStrategy (MSTR), now rebranded as Strategy Inc., has remade itself from a decades-old business-intelligence software firm into one of the largest corporate holders of Bitcoin. In this episode, we unpack that dramatic pivot — Michael Saylor’s decision to turn the company’s treasury and capital-raising power into an active Bitcoin accumulation vehicle — and how that has transformed the company’...

Circle (CRCL) is staking a claim as a cornerstone of the digital-dollar era with USDC at its center. In this episode, we trace its long road to a public listing, its pivot from payments and exchange ownership to focusing on stablecoins, and how a high-profile de-pegging moment tested—and ultimately showcased—its commitment to transparency and regulatory compliance. Circle’s model—earning yield on...

The Walt Disney Company (DIS) is the century-old entertainment giant built on iconic characters, massive franchises, and a uniquely integrated business model. In this episode, we unpack Disney’s evolution from Mickey Mouse and Snow White to a modern media-and-experiences empire—how content studios, TV networks, streaming (Disney+, Hulu, ESPN+), theme parks, merchandise, and new bets like gaming fo...

Cisco Systems (CSCO) is the veteran architect of the internet, famous for building the network “pipes” that power corporate IT. In this episode, we unpack its transformation from a hardware-first stalwart into a software-and-services player—driving a subscription shift and moving aggressively into cybersecurity, collaboration (Webex), and observability via major acquisitions like Splunk. We weigh...

Advanced Micro Devices ($AMD) has evolved from Intel’s scrappy underdog into a bona fide chip powerhouse. In this episode, we trace the turnaround under CEO Lisa Su—the shift to high-performance computing with Zen/Ryzen and EPYC, a fabless model that leverages TSMC, and a diversified footprint across data centers, PCs, gaming (including console semi-custom chips), and embedded markets. We unpack A...

CoreWeave (CRWV) has emerged as a focused player in the AI cloud compute race, transforming from a crypto-mining outfit into a purpose-built GPU powerhouse. In this episode, we unpack that dramatic pivot, its tight partnership with NVIDIA, the niche business model of renting high-performance GPUs to AI developers, and the ways it’s raced to build out data centers and win marquee customers. We also...

JFrog Ltd. (FROG) brands itself the “Liquid Software” company, and in this episode we unpack how a 2008 Israeli startup turned its Artifactory idea into a mission-critical platform for managing the software supply chain. They’ve built a SaaS-focused, land-and-expand model that supports both on‑prem and cloud environments—appealing to large, hybrid enterprises that need a neutral, universal source...

Globus Medical (GMED) is a fast-growing musculoskeletal and spine surgery player built on aggressive product innovation and acquisitive expansion. In this episode we unpack its origin story—founded in 2003 by a former Synthes executive, an early lawsuit, and a string of buys that brought tech like the ExcelsiusGPS surgical robot and 3D‑printed implants into its portfolio—culminating in the transfo...

CAVA ($CAVA) has sprinted from a single Maryland restaurant to a national fast-casual Mediterranean contender with a Chipotle-style assembly line, grocery shelf presence, and a string of strategic moves (including the big Zoës Kitchen play) that put it squarely on the map. The brand leans into fresh, customizable bowls and dips, owns all its stores to keep tight operational control, and is pushing...

Novo Nordisk has surged from a century-old Danish insulin maker into a global powerhouse on the back of its GLP-1 drugs, Ozempic and Wegovy. In this episode, we unpack that meteoric rise—from historic roots and blockbuster treatments that reshaped Denmark’s economy to the structural risks beneath the shine: extreme reliance on a single drug class, growing competition (notably from Eli Lilly), pric...

Denny’s (DENN) is a classic American diner that grew from a 1953 California donut stand into a 24/7 breakfast institution, famous for its Grand Slam and broad national footprint. In this episode, we look at a brand that’s chosen an asset-light, franchise-heavy model to scale quickly and collect steady fees—but that same model makes consistency and quality control a persistent challenge. Denny’s be...

Palantir Technologies ($PLTR) is one of tech’s most talked-about and secretive companies. Founded in 2003 with early backing from figures connected to the intelligence community, Palantir built powerful data-operating systems—Gotham for government and Foundry for commercial users—that stitch together messy, sensitive data to drive high-stakes decisions. After going public, it has aggressively push...

Adobe (ADBE) remains a dominant force in the creative and digital experience world. In this episode, we unpack its rise from the PostScript pioneers to the creators of Photoshop and Illustrator, the game-changing shift to the Creative Cloud subscription model, and how that recurring-revenue strategy reshaped the business. Is Adobe able to keep innovating and stay indispensable to creators and busi...

UnitedHealth Group (UNH) is a healthcare behemoth built by decades of aggressive acquisitions and vertical integration. In this episode, we unpack its evolution from a claims processor to a two-pronged powerhouse — UnitedHealthcare (insurance) and Optum (care delivery, data analytics, and pharmacy services) — and how that integrated model gives it scale, strategic reach, and many ways to grow. We...

PayPal Holdings, Inc. is a longtime fintech giant that grew from Confinity/X.com roots into eBay’s checkout engine and, after a 2015 spinoff, expanded via acquisitions like Venmo, Xoom, and Braintree into a full-service payments platform. Its core model—transaction fees plus “other value‑added services” (BNPL, interest on balances, lending, partnerships)—leans on powerful two‑sided network effects...

Apple Inc. ($AAPL) is a four-trillion-dollar behemoth built on decades of product-led reinvention and a tightly controlled “walled garden.” In this episode we trace its journey from a 1976 garage startup to the iPhone era that made it dominant, then unpack its current playbook: a vertically integrated ecosystem that drives hardware sales and high-margin, recurring Services (expected to top $100B),...

Idaho Strategic Resources ($IDR) is a small gold producer with a big twist: it operates the Golden Chest Mine while holding the largest rare earth element (REE) land package in the U.S. In this episode, we unpack how the company uses gold production and its own mill to self-fund aggressive REE exploration, the strategic appeal of domestic critical-minerals exposure, and the promise of a hybrid bus...

Meta Platforms ($META) is a social-media giant — born as Facebook, now reaching over 3 billion daily users — that prints cash through an ad-driven engine (over 97% of revenue) while simultaneously pouring billions into a visionary but costly metaverse bet. In this episode we unpack its dominant ad business, the Reality Labs drain, and the strategic tension between short-term profitability and long...

Microsoft (MSFT) is a tech giant that reinvented itself from a legacy software powerhouse into a cloud-and-AI leader under Satya Nadella. In this episode we trace the arc from MS-DOS and Windows dominance to the 3-pillar modern model—Productivity & Business Processes (Microsoft 365, LinkedIn, Dynamics), Intelligent Cloud (Azure and cloud services), and More Personal Computing (Windows, Surface...

Amazon.com, Inc. (AMZN) has grown from Jeff Bezos’s 1994 garage bookstore into a sprawling “everything” ecosystem anchored by e-commerce, Prime subscriptions, a fast-growing ad business, and cloud titan AWS. In this episode we unpack that flywheel alongside its huge logistics moat and data-driven advantages. The upside is big: AI investments, further AWS expansion, and moves into healthcare and gr...

Granite Construction ($GVA) brings over a century of experience to the infrastructure sector. In this episode, we explore its journey from a California contractor to a major civil construction player, examining its strengths, challenges, and strategy shifts. We highlight Granite’s disciplined bidding, robust project backlog, and dual construction-and-materials model, as well as risks from thin mar...

Wellgistics Health, Inc. ($WGRX) is carving a niche in healthcare logistics and distribution—a critical but notoriously thin-margin industry. In this episode, we explore its early-stage story: limited public track record, high compliance demands, and the tightrope between agility and scale. With growing needs for cold-chain reliability, specialty pharma handling, and DSCSA traceability, Wellgistic...

Minerva Neurosciences ($NERV) is a clinical-stage biotech with a tight focus on CNS disorders, led by roluperidone for the negative symptoms of schizophrenia—an area with major unmet need and first-in-class potential. In this episode, we unpack its single-asset concentration, mixed study history and regulatory pushback, and a lean, partner-friendly model that could support a focused U.S. launch wh...